US 9447419
RNAi-mediated inhibition of tumor necrosis factor α-related conditions
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 9447419 (RNAi-mediated inhibition of tumor necrosis factor α-related conditions) held by Arrowhead Pharmaceuticals, Inc. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61P, A61P11/02